Evidence Sources

Browse 403 of 8594 research sources from PubMed and clinical trials (page 1 of 9)

Filter by source class:
All Pubmed Article 8110 Cochrane Review 403 Ods Factsheet 63 Openfda Safety 17 Clinical Trial 1
Year Title Citations Type PMID Related
2026 Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy
DOI: 10.1002/14651858.CD001939.pub5
 — Cochrane Review 41542879
2026 Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
DOI: 10.1002/14651858.CD009733.pub4
 — Cochrane Review 41670018
2025 Silymarin for adults with metabolic dysfunction-associated steatotic liver disease
DOI: 10.1002/14651858.CD015524.pub2
 — Cochrane Review 40552569
2025 Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
DOI: 10.1002/14651858.CD006023.pub4
 4 OA Cochrane Review 40576086
2025 Calcium supplementation commenced before pregnancy for preventing hypertensive disorders and related problems
DOI: 10.1002/14651858.CD011192.pub4
 4 OA Cochrane Review 40965861
2025 Omega-3 fatty acid supplementation for distal symmetrical peripheral neuropathy in adults with diabetes mellitus
DOI: 10.1002/14651858.CD014623.pub2
 — Cochrane Review 40990181
2025 Magnesium supplementation for migraine prophylaxis
DOI: 10.1002/14651858.CD016307
 — Cochrane Review 41216917
Electrolytes
2025 Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
DOI: 10.1002/14651858.CD001059.pub6
 3 OA Cochrane Review 41330480
2024 Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
DOI: 10.1002/14651858.CD013823.pub2
 21 OA Cochrane Review 38189492
2024 Alpha-lipoic acid for diabetic peripheral neuropathy
DOI: 10.1002/14651858.CD012967.pub2
 15 OA Cochrane Review 38205823
2024 Prebiotics for induction and maintenance of remission in ulcerative colitis
DOI: 10.1002/14651858.CD015084.pub2
 10 OA Cochrane Review 38501688
2024 Calcium supplementation for people with overweight or obesity
DOI: 10.1002/14651858.CD012268.pub2
 4 OA Cochrane Review 38721870
2024 Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
DOI: 10.1002/14651858.CD009749.pub3
 9 OA Cochrane Review 38837771
Dhea
2024 Vitamin D supplementation for women during pregnancy
DOI: 10.1002/14651858.CD008873.pub5
 33 OA Cochrane Review 39077939
2024 Daily oral iron supplementation during pregnancy
DOI: 10.1002/14651858.CD004736.pub6
 25 OA Cochrane Review 39145520
2024 Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery
DOI: 10.1002/14651858.CD011800.pub2
 4 OA Cochrane Review 39351881
2024 Vitamin E for people with non-alcoholic fatty liver disease
DOI: 10.1002/14651858.CD015033.pub2
 12 OA Cochrane Review 39412049
2024 Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
DOI: 10.1002/14651858.CD007079.pub4
 2 OA Cochrane Review 39560075
2024 Omega-3 fatty acid supplementation for depression in children and adolescents
DOI: 10.1002/14651858.CD014803.pub2
 5 OA Cochrane Review 39564892
2024 Exercise for osteoarthritis of the knee
DOI: 10.1002/14651858.CD004376.pub4
 48 OA Cochrane Review 39625083
2023 Calcium and vitamin D for increasing bone mineral density in premenopausal women
DOI: 10.1002/14651858.CD012664.pub2
 52 OA Cochrane Review 36705288
2023 Vitamin D for the management of asthma
DOI: 10.1002/14651858.CD011511.pub3
 71 OA Cochrane Review 36744416
2023 Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
DOI: 10.1002/14651858.CD011507.pub3
 31 OA Cochrane Review 36790138
2023 Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo
DOI: 10.1002/14651858.MR000055.pub2
 12 OA Cochrane Review 36877132
2023 Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
DOI: 10.1002/14651858.CD009384.pub3
 35 OA Cochrane Review 36994923
2023 Prebiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
DOI: 10.1002/14651858.CD015133.pub2
 14 OA Cochrane Review 37262358
2023 Non-Chinese herbal medicines for functional dyspepsia
DOI: 10.1002/14651858.CD013323.pub2
 14 OA Cochrane Review 37323050
2023 Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
DOI: 10.1002/14651858.CD005496.pub6
 79 OA Cochrane Review 37493095
2023 Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
DOI: 10.1002/14651858.CD000254.pub5
 44 OA Cochrane Review 37702300
2023 Synbiotics, prebiotics and probiotics for people with chronic kidney disease
DOI: 10.1002/14651858.CD013631.pub2
 45 OA Cochrane Review 37870148
Prebiotics
2022 Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
DOI: 10.1002/14651858.CD008524.pub4
 71 OA Cochrane Review 35294044
2022 Probiotics for preventing acute upper respiratory tract infections
DOI: 10.1002/14651858.CD006895.pub4
 127 OA Cochrane Review 36001877
2022 Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews
DOI: 10.1002/14651858.CD012337.pub2
 104 OA Cochrane Review 36053030
2022 Antidepressants for hip and knee osteoarthritis
DOI: 10.1002/14651858.CD012157.pub2
 30 OA Cochrane Review 36269595
2022 Carnitine supplements for people with chronic kidney disease requiring dialysis
DOI: 10.1002/14651858.CD013601.pub2
 17 OA Cochrane Review 36472884
Carnitine
2021 Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates
DOI: 10.1002/14651858.CD012797.pub2
 49 Cochrane Review 33710626
2021 Zinc supplementation for improving pregnancy and infant outcome
DOI: 10.1002/14651858.CD000230.pub6
 68 Cochrane Review 33724446
2021 Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
DOI: 10.1002/14651858.CD007535.pub4
 23 Cochrane Review 34085287
2021 Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
DOI: 10.1002/14651858.CD013157.pub2
 22 OA Cochrane Review 34280304
2021 Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews
DOI: 10.1002/14651858.CD013092.pub2
 129 OA Cochrane Review 34564844
Anemia
2021 Dietary supplements for chronic gout
DOI: 10.1002/14651858.CD010156.pub3
 6 Cochrane Review 34767649
2021 Vitamin C supplementation for prevention and treatment of pneumonia
DOI: 10.1002/14651858.CD013134.pub3
 12 Cochrane Review 34791642
2021 Omega-3 fatty acids for depression in adults
DOI: 10.1002/14651858.CD004692.pub5
 55 Cochrane Review 34817851
Depression
2021 Propionyl-L-carnitine for intermittent claudication
DOI: 10.1002/14651858.CD010117.pub2
 7 OA Cochrane Review 34954832
Carnitine
2021 Coenzyme Q10 for heart failure
DOI: 10.1002/14651858.CD008684.pub3
 58 OA Cochrane Review 35608922
2020 Resveratrol for adults with type 2 diabetes mellitus
DOI: 10.1002/14651858.CD011919.pub2
 75 OA Cochrane Review 31978258
2020 Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
DOI: 10.1002/14651858.CD003177.pub5
 284 Cochrane Review 32114706
2020 Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
DOI: 10.1002/14651858.CD007137.pub6
 132 Cochrane Review 32232984
2020 Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age
DOI: 10.1002/14651858.CD010205.pub2
 34 OA Cochrane Review 32266964
2020 Omega-3 fatty acid supplementation for cystic fibrosis
DOI: 10.1002/14651858.CD002201.pub6
 33 OA Cochrane Review 32275788